|
| A systematic review and Meta-analysis of the efficacy of Xiaoaiping injection combined with first-line chemotherapy in the treatment of advanced gastric cancer |
| Hits 219 Download times 160 Received:April 08, 2024 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2024.07.10 |
| Key Words
gastric cancer;Xiaoaiping injection;first-line chemotherapy;systematic review;Meta-analysis |
| Author Name | Affiliation | E-mail | | KUANG Ziyu | Beijing University of Chinese Medicine, Beijing 100029, China
Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China | | | LIU Kexin | Beijing University of Chinese Medicine, Beijing 100029, China
Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China | | | LI Jie | Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China | drjieli2007@126.com |
|
| Abstract
|
| [Objective] To evaluate the efficacy and safety of Xiaoaiping injection combined with first-line chemotherapy in the treatment of advanced gastric cancer. [Methods] We searched for randomized controlled trials（RCTs） of Xiaoaiping injection combined with first-line chemotherapy regimen in the treatment of advanced gastric cancer in five Chinese and English databases published in CNKI，Wanfang Database，VIP Database，Pubmed and Web of Science，and the time range was set from the establishment of each database to October 27，2023，and the risk of bias assessment and Meta-analysis of studies that met the inclusion criteria were conducted. [Results] A total of 10 RCTs were included，including 814 patients with advanced gastric cancer，and in terms of short-term efficacy，Xiaoaiping injection combined with first-line chemotherapy regimen could improve the objective response rate（ORR） [RR：1.35，95%CI（1.15，1.58），P=0.0002] and increase the Karnofsky performance score（KPS） [RR：1.62，95%CI（1.16，2.26），P=0.005] and the number of grade 3-4 adverse events（SAEs） was lower than that of chemotherapy alone [RR：0.32，95%CI（0.06，0.90），P=0.04]；in terms of long-term survival benefit，Xiaoaiping injection combined with first-line chemotherapy was significantly more effective in progression-free survival（PFS） [HR：0.32，95%CI（0.17，0.62），P=0.001] and overall survival（OS） [HR：0.33，95%CI（0.16，0.65），P=0.002] was better than chemotherapy alone，and the GRADE results showed that ORR，KPS scores，PFS，and OS were of low quality，while SAE was of very low quality. [Conclusion] Xiaoaiping injection combined with first-line chemotherapy has good clinical efficacy and safety，but the methodological quality of the included literature is low，and more comprehensive large-sample，multicenter，randomized double-blind controlled trials are needed for verification. |
|
|
|
|
|
|
|
